Summary Info
Regarding the CMB Application for Capital Increase Through Rights Issue
Update Notification Flag
Yes
Correction Notification Flag
No
Postponed Notification Flag
No
Board Decision Date
21.08.2025
Authorized Capital (TL)
10.000.000.000
Paid-in Capital (TL)
7.000.000.000
Target Capital (TL)
10.000.000.000
Rights Issue (Via Preemptive Right)
Share Group Info
Paid-in Capital (TL)
Preemptive Rights Amount (TL)
Preemptive Rights Rate (%)
Preemptive Rights Price
Share Group Issued
New Shares'' ISIN
Form
Preemptive Rights ISIN Code
Unused Rights Amount (TL)
Amount of Shares Cancelled (TL)
CANTE, TRECAN200011
7.000.000.000
3.000.000.000,000
42,85714
1,00
CANTE, TRECAN200011
Registered
Paid-in Capital (TL)
Preemptive Rights Amount (TL)
Preemptive Rights Rate (%)
Unused Rights Amount (TL)
Amount of Shares Cancelled (TL)
TOTAL
7.000.000.000
3.000.000.000,000
42,85714
Currency Unit
TRY
Other Aspects To Be Notified
Number of Articles of Association Item To Be Amended
6
Property of Increased Capital Shares
Dematerialized Share
Additional Explanations
In accordance with the decision of the Company's Board of Directors dated August 21, 2025, an application was submitted to the Capital Markets Board on September 12, 2025 (today) with the attached draft prospectus for the approval of:

Pursuant to the authority granted by Article 6 of the Company's Articles of Association, within the scope of the Company's registered capital ceiling of TL 10,000,000,000, The Company's issued capital of 7,000,000,000 TL shall be increased by 3,000,000,000 TL to 10,000,000,000 TL, with 42.85714% of the increase being paid in cash (for value), The entire 3,000,000,000 shares representing the increased capital of 3,000,000,000 TL shall be issued as registered shares with a nominal value of 1.00 TL without restricting the rights of shareholders to acquire new shares, and the 3,000,000, 000 TL, and to grant shareholders their new share subscription rights at a price of 1 TL per share with a nominal value of 1 TL.

The draft prospectus has not yet been approved by the Capital Markets Board, and there may be differences between the final approved prospectus and the draft prospectus.

In contradiction between the Turkish and English versions of this document, the Turkish version shall prevail.
Supplementary Documents
Appendix: 1
Can2Termik_İzahname_Taslak.pdf